ArticleRSC advances2024

Levofloxacin reposition-based design: synthesis, biological evaluation of new levofloxacin derivatives targeting topoisomerase II beta polymerase as promising anticancer agents, molecular docking, and physicochemical characterization.

Zeinab Mahmoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.